TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ENTX

Entera Bio Ltd

Healthcare · Biotechnology

2.70$ -2.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ENTX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – -52.8% +54.7% +56.4% -76.5% -89.6% +1,192.9% -76.8%
– +25.0% +22.9% -100.0% – -53.3% +78.5% -72.9% -44.6% +207.1% -75.6%
– – – – -142.4% – +26.9% -83.3% -269.7% – -433.3%
– +25.2% +4.5% +207.7% -18.3% -8.1% +5.8% -13.6% -23.8% +1.0% +33.5%
– +71.4% +215.4% -66.8% +50.6% +14.2% +16.3% +27.5% -38.9% +15.0% +8.4%
– +45.0% +111.3% +0.2% -1.0% +0.4% +10.0% +5.1% -31.9% +8.0% +20.2%
– – – -195.8% – – – – – – –
– – – – – +1,560.7% -97.9% +89,562.1% – – –
– – – – – – – – – – –
– – – – -84.9% -76.2% -395.0% – -78.8% -51.7% +82,250.0%
– – – – – – – – – – –
– – – – – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?